Skip to content

CATUG and Crystal Bio Establish Strategic Partnership, Launching “CATUG-Crystal” Joint Lab Dedicated to Advanced Nucleic Acid Analytical Services

CAMBRIDGE, Massachusetts and Cranbury, New Jersey, February 21, 2024, – CATUG Inc. (CATUG) and Crystal Bio, a member of Crystal Pharmatech, announced today a long-term strategic partnership towards providing advanced nucleic acid based drug analytical services. Together, CATUG, a distinguished global entity specializing in integrated nucleic acid and drug delivery CRDMO services, and Crystal Bio, a premier provider of analytical services for biologics in CMC, preclinical and clinical stages, will provide clients with comprehensive nucleic acid services and analytical solutions in the North American market.
 
Driven by the shared mission and vision, both parties are excited to launch the CATUG-Crystal Joint Lab, aiming to serve as a premier hub for tackling diverse analytical challenges in the field of mRNA and nucleic acid therapeutics. Its objective is to deliver advanced characterization capabilities and a full range of analytical services to support various stages of drug development for nucleic acid-based therapeutics.With joint lab locations in New Jersey and Boston, the collaborative effort is committed to providing services with a focus on local accessibility, quality, speed, and flexibility.
 
“Given the rapid evolution of mRNA and nucleic acid therapeutics, there is a growing demand for adept analytical solutions. CATUG has been steadfast in its mission to pioneer top-notch platforms supporting comprehensive solutions in nucleic acid-based therapeutics. Its analytical platforms have been meticulously developed, boasting over 80 platform methods tailored for release & stability testing and extended characterization of DNA, RNAs, and diverse nanoparticle formulations. We are honored to form this partnership with CATUG. Together, we anticipate providing top-notch local analytical services to support nucleic acid discovery and development endeavors”, said Dr. Alex Chen, co-founder and CEO of Crystal Pharmatech.
 
Dr. Lin Jin, co-founder and CTO of CATUG, also expressed the excitement of this partnership saying, “Crystal Bio is the premier CRO for intricate analytical challenges in CMC, preclinical, and clinical samples for a range of biologic products, including proteins, peptides, antibodies, ADCs, nucleic acids, and more. We are truly thrilled about our partnership with Crystal Bio. This partnership underscores both parties’ shared vision for innovation, quality and excellence. The launch of CATUG-Crystal joint lab exemplifies our commitment to delivering advanced services crucial for various stages of drug development. Together, we are poised to set new standards in the industry, offering cutting-edge analytical solutions tailored to the evolving needs of our clients.”
 
CATUG and Crystal Bio are confident that by combining the local analytical prowess of Crystal Bio with CATUG’s proficient expertise in integrated nucleic acids analytical platforms, CATUG-Crystal will deliver best-in-class analytical services and drive advancements in nucleic acid-based drug development in the North American market.
 
About CATUG
CATUG is a specialized Contract Research and Development Manufacturing Organization (CRDMO) and a one-stop solution in nucleic acid-based therapeutics through its leading DNA, RNA, LNP, and analytical platforms. With strong expertise and know-how CATUG aims to provide customized solutions in the life cycle of mRNA therapeutics, gene editing, and gene and cell therapy development. For more detailed information, please visit https://catug.bio/.
 
About Crystal Bio
Built from Crystal Pharmatech, the leader in crystal form and formulation services, Crystal Bio is a dedicated biologics analytical CRO in the USA. Crystal Bio is committed to addressing the intricate and analytical challenges in CMC, pre-clinical, and clinical samples for biologic products with speed and complete flexibility. For more detailed information, please visit https://www.crystalpharmatech.com/crystal-bio/.
 
 
Contact:
Lin Jin, Ph.D.
617-807-0802
info@catug.bio